Close
4

Seqens Seqens

X

Company profile for Renibus Therapeutics

  • Webinars & Exhibitions

PharmaCompass
About the Company
Related CompaniesRelated Companies
Rénibus Therapeutics Inc. (RTI) is a clinical-stage biotech company focused on the development of novel pharmacologic therapies for acute and chronic kidney disease. Acute Kidney Injury (AKI) remains a significant, unmet medical need with no approved treatment. Postoperative AKI occurs in approximately 30% of patients undergoing cardiac surgery and significantly increases the risk of death (Rosner 2006). Progression to chr...
Rénibus Therapeutics Inc. (RTI) is a clinical-stage biotech company focused on the development of novel pharmacologic therapies for acute and chronic kidney disease. Acute Kidney Injury (AKI) remains a significant, unmet medical need with no approved treatment. Postoperative AKI occurs in approximately 30% of patients undergoing cardiac surgery and significantly increases the risk of death (Rosner 2006). Progression to chronic kidney disease (CKD) within 24 months occurs in approximately 15-20% of patients who survive AKI (Chawla 2012).

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
Renibus Therapeutics
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
181 Grand Ave, Suite 225, Southlake, TX 76092
Telephone
Telephone
682-285-1711
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY